Literature DB >> 21865415

Benign multiple sclerosis: a new definition of this entity is needed.

Jorge Correale1, Isabel Peirano, Lucas Romano.   

Abstract

BACKGROUND: To study a cohort of benign multiple sclerosis (BMS) patients beyond physical disability, including the evaluation of cognitive and social function, as well as fatigue, pain and MRI studies.
METHODS: A cohort of 342 patients was prospectively followed for 10.9 ± 0.71 years. Forty-three patients (12.5%) met the BMS diagnosis criteria [Expanded Disability Status Scale (EDSS) < 3 after at least 10 years' disease duration], undergoing full neurological examination every 6 months. Neuropsychological status, pain, fatigue, social functioning and work-related disability, as well as brain MRIs, were assessed yearly.
RESULTS: By the end of follow-up, 20 of 43 BMS patients (47%) had suffered cognitive impairment and 23 (53.3%) referred depression. Furthermore, 21 (48.8%) reported significant changes in pain intensity, with fatigue and environmental severity scores significantly increasing over time in 33-35% of patients. Finally, 32 BMS patients (74%) showed significant increase in the number of new or enlarging T2 lesions, gadolinium-enhanced lesions, and persistent black holes, without changes in EDSS. Thirty-five of 43 patients (81%) fulfilling the BMS diagnostic criteria showed significant worsening of cognitive function, fatigue, pain or depression during the 10-year follow-up.
CONCLUSIONS: Currently accepted criteria for BMS diagnosis may cause overestimation of true prevalence, underscoring the need for routine monitoring of non-motor symptoms and imaging studies, to help physicians improve diagnostic accuracy as well as therapeutic decision-making in this subgroup of MS patients.

Entities:  

Mesh:

Year:  2011        PMID: 21865415     DOI: 10.1177/1352458511419702

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  14 in total

Review 1.  Benign multiple sclerosis: does it exist?

Authors:  Jorge Correale; María C Ysrraelit; Marcela P Fiol
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

2.  Spatial distribution of white matter degenerative lesions and cognitive dysfunction in relapsing-remitting multiple sclerosis patients.

Authors:  Natalia Nowaczyk; Alicja Kalinowska-Łyszczarz; Włodzimierz Paprzycki; Sławomir Michalak; Radosław Kaźmierski; Mikołaj A Pawlak
Journal:  Neurol Neurochir Pol       Date:  2019-02-11       Impact factor: 1.621

3.  Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.

Authors:  Lutz Achtnichts; Oded Gonen; Daniel J Rigotti; James S Babb; Yvonne Naegelin; Iris-Katharina Penner; Kerstin Bendfeldt; Jochen Hirsch; Michael Amann; Ludwig Kappos; Achim Gass
Journal:  Eur J Radiol       Date:  2013-09-04       Impact factor: 3.528

Review 4.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

5.  Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple Sclerosis.

Authors:  E Ghione; N Bergsland; M G Dwyer; J Hagemeier; D Jakimovski; D P Ramasamy; D Hojnacki; A A Lizarraga; C Kolb; S Eckert; B Weinstock-Guttman; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-06       Impact factor: 3.825

6.  Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis.

Authors:  Maxim Bester; Mariana Lazar; Maria Petracca; James S Babb; Joseph Herbert; Robert I Grossman; Matilde Inglese
Journal:  J Neurol Sci       Date:  2013-05-01       Impact factor: 3.181

7.  Cytokine-chemokine and cognitive profile of multiple sclerosis patients with predominant optic nerve and spinal cord involvement.

Authors:  Melis Şen; Ece Akbayır; Özlem Mercan; Erdil Arsoy; Mehmet Gencer; Vuslat Yılmaz; Cem İsmail Küçükali; Erdem Tüzün; Recai Türkoğlu
Journal:  J Spinal Cord Med       Date:  2019-09-26       Impact factor: 1.985

8.  Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.

Authors:  Ashley D Radomski; Christopher Power; Scot E Purdon; Derek J Emery; Gregg Blevins; Kenneth G Warren; Esther Fujiwara
Journal:  BMC Neurol       Date:  2015-04-23       Impact factor: 2.474

9.  Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC).

Authors:  Robert Zivadinov; Diane L Cookfair; Lauren Krupp; Aaron E Miller; Neil Lava; Patricia K Coyle; Andrew D Goodman; Burk Jubelt; Michael Lenihan; Joseph Herbert; Malcolm Gottesman; David H Snyder; Brian R Apatoff; Barbara E Teter; Allan B Perel; Frederick Munschauer; Bianca Weinstock-Guttman
Journal:  BMC Neurol       Date:  2016-07-15       Impact factor: 2.474

10.  Optical coherence tomography and T cell gene expression analysis in patients with benign multiple sclerosis.

Authors:  John Soltys; Qin Wang; Yang Mao-Draayer
Journal:  Neural Regen Res       Date:  2017-08       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.